Predictive Oncology (POAI) Stock Already Doubled This Year: What Next?

Investors who are currently on the lookout for penny stocks could consider having a look at the Predictive Oncology Inc (NASDAQ: POAI) stock.

Predictive Oncology (POAI) Stock Already Doubled This Year: What Next?

In recent times, the stock has gained notable momentum but there has been no news regarding the company in recent days. The stock has gained almost 105% so far this year. The company is involved in providing artificial intelligence-powered solutions to the drug discovery and personalized medicine space. Back on March 22, the company made a significant announcement. At the time, Predictive announced that it appointed J. Melville Engle as the new Chief Executive Officer.

Related:  Active Stock Evaluation: Intuitive Surgical (NASDAQ: ISRG)

It is necessary to note that Engle is going to continue to serve in his position as the Chairman of the Predictive Oncology board. Engle had joined the company’s board back in 2016 and had been appointed as the Chairman last year. He is a seasoned executive, who has served in different executive roles in the biotech and healthcare space for more than two decades. Investors could consider adding the stock to their watch lists at this point.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.